News

Последни новини

Новини

thumbnail_Group 642.png

Group 642.png

Through sincere testimonies and inspiring conversations, experts, parents, and public figures shared a single, powerful message: caring for premature babies is not solely a medical journey — it is a lifelong mission fueled by courage, hope, and unconditional love.

THE GREAT STORIES OF LITTLE HEROES – BECUTAN Conference in Honor of World Prematurity Day

THE GREAT STORIES OF LITTLE HEROES

ALKALOID achieved record consolidated sales of EUR 246.6 million, consolidated exports of EUR 160.4 million, and invested EUR 15 million in the January – September 2025 period.

ALKALOID – Operating Results for the January – September 2025 period

ADDRESS OF THE CEO/MB PRESIDENT OF ALKALOID AD SKOPJE

Address of the CEO

ALKALOID reports a 7% increase in consolidated sales, reaching €164.2 million, with a consolidated net profit of €13.9 million and investments totaling €10 million during the period January – June 2025.

ALKALOID – Operating Results for the Period January – June 2025

Alkaloid AD Skopje has earned a bronze medal from EcoVadis, a globally renowned sustainability assessment platform. This award represents a significant leap from its 2024 “Committed” rating, which indicated an early-stage alignment with ESG (Environmental, Social, Governance) criteria under EcoVadis’s rigorous evaluation process.

ALKALOID REACHES NEW MILESTONE IN SUSTAINABILITY – HONORED WITH ECOVADIS BRONZE MEDAL 

Over the past 5 years, Alkaloid has obtained 119 trademark registrations in the Bulgarian market, as documented by the National Map of Intellectual Property of the Republic of Bulgaria project

Alkaloid Recognized for Contribution to Innovative Development and Competitiveness in Bulgaria

As the holder of the first international value-added medicine patent – liquid Omeprazole, ready to use – Alkaloid sponsored the First International Conference on Modern Approaches to GERD Treatment in Pediatric Patients, held in Zagreb, Croatia.

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE: FIRST INTERNATIONAL CONFERENCE ON INNOVATIVE SOLUTIONS IN PEDIATRIC GERD TREATMENT HELD IN ZAGREB

ALKALOID OPENS NEW HORIZONS IN GERD TREATMENT WITH LIQUID OMEPRAZOLE

To fully integrate all laboratory processes, centralize the management of data and processes, ensure their traceability for product control, maintain regulatory compliance, and support continuous advancement, the company has begun implementing the AlkaLIMS software platform.

ALKALOID TAKES A STEP FURTHER TOWARD COMPLETE DIGITALIZATION

Alkaloid AD Skopje Makes a Groundbreaking Achievement in Treating Reflux Esophagitis and GERD with the World's First Patent for Liquid Omeprazole 

ALKALOID HOLDS FIRST LEADERSHIP DEVELOPMENT EVENT

Alkaloid - awarded 2023 Patent of the Year for groundbreaking liquid Omeprazole

"1st Cefixime Global Meeting" in Istanbul, supported by Alkaloid

Since it was first established back in August 1936, Alkaloid has grown and developed through very tumultuous and challenging decades to become the modern, export-oriented company with nearly 3,000 employees that it is today.

Our Brands are Part of People’s Lives - interview of the CEO / MB President of Alkaloid AD Skopje, Zhivko Mukaetov, for The Region magazine 

The Western Balkans Six Chamber Investment Forum Presents Alkaloid with the "Lead Champion Investor in the Region" award for investing €104.1 million in the past five years

The Western Balkans Six Chamber Investment Forum Presents Alkaloid with the Lead Champion Investor in the Region award for investing €104.1 million in the past five years

Visit your local Alkaloid website

Serbia

Romania

CIS

Croatia

Ukraine

Bulgaria

Bosnia and Herzegovina